18F‐FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytoma

18F‐FDG PET/CT imaging: A supplementary understanding of pulmonary sclerosing pneumocytoma

Background We sought to investigate the clinical features and 18F‐FDG PET/CT characteristics of pulmonary sclerosing pneumocytoma (PSP). Methods We retrospectively reviewed and comparatively analyzed 18F‐FDG PET/CT imaging results of 22 patients with diagnosed PSP in our hospital from November 2009...

Full description

Bibliographic Details
Main Authors:	Jie Xu, Youwen Dong, Guotao Yin, Wei Jiang, Zhen Yang, Wengui Xu, Lei Zhu
Format:	Article
Language:	English
Published:	Wiley 2019-07-01
Series:	Thoracic Cancer
Subjects:	18Fluorine 2‐fluoro‐2‐deoxy‐d‐glucose positron emission tomography and computed tomography pulmonary sclerosing pneumocytoma
Online Access:	https://doi.org/10.1111/1759-7714.13100

Similar Items

Pulmonary sclerosing pneumocytoma with multiple satellite nodules mimicking tuberculosis
by: Min A Lee, et al.
Published: (2018-06-01)

Appropriateness criteria of FDG PET/CT in oncology
by: Archi Agrawal, et al.
Published: (2015-04-01)

A case of pulmonary sclerosing pneumocytoma diagnosed preoperatively using transbronchial cryobiopsy
by: Yutaka Muto, et al.
Published: (2021-01-01)

Central and peripheral pulmonary sclerosing pneumocytomas: multi-phase CT study and comparison with Ki-67
by: Zhang Yanli, et al.
Published: (2023-09-01)

Use of CT in a case of sclerosing pneumocytoma in pulmonary sequestration
by: Chao Chen, et al.
Published: (2024-04-01)

Sclerosing Pneumocytoma: A Ten-Year Experience at a Western Balkan University Hospital
by: Aleksandra Lovrenski, et al.
Published: (2019-01-01)

Pulmonary sclerosing pneumocytoma and mortality risk
by: So Jeong Kim, et al.
Published: (2022-11-01)

Analysis of Clinical Characteristics of 35 Cases  of Pulmonary Sclerosing Pneumocytoma
by: Xiaojing LIU, et al.
Published: (2020-12-01)

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
by: Sébastien Thureau, et al.
Published: (2018-10-01)

Sclerosing pneumocytoma with metastasis to the mediastinal and regional lymph nodes
by: Xiaojun Wang, et al.
Published: (2018-01-01)

PET/CT and contrast-enhanced CT: making a difference in assessment and staging of patients with lymphoma
by: Ashraf Anas Zytoon, et al.
Published: (2020-10-01)

Large pulmonary sclerosing pneumocytoma in a young female: A rare lung tumor
by: Do Kyun Kang, et al.
Published: (2021-06-01)

Pulmonary sclerosing pneumocytoma: clinical features and prognosis
by: Quan Zheng, et al.
Published: (2022-04-01)

Magnetic resonance imaging findings of pulmonary sclerosing pneumocytoma: a case report and literature review
by: Yang Li, et al.
Published: (2023-09-01)

Brain metastases assessment by FDG-PET/CT: can it eliminate the necessity for dedicated brain imaging?
by: Mamdouh A. Zidan, et al.
Published: (2020-11-01)

Correlation Between Pulmonary Sclerosing Pneumocytoma Features and MSCT Imaging Manifestations in 34 Patients: Implications for Precision Medicine
by: Gen Xu, et al.
Published: (2021-03-01)

Case Report: Rare Pulmonary Sclerosing Pneumocytoma: Large, Multiple, Metastatic, and Fatal
by: Weidong Zhang, et al.
Published: (2021-08-01)

Case of pulmonary pneumocytoma: A probable cytological diagnosis with histopathological confirmation
by: Mayank Gupta, et al.
Published: (2014-01-01)

Volumetric parameters on 18F-FDG PET/CT predict the survival of patients with gastric cancer associated with their expression status of c-MET
by: Guobing Liu, et al.
Published: (2019-08-01)

PET Imaging in Bladder Cancer: An Update and Future Direction
by: Jules Zhang-Yin, et al.
Published: (2023-04-01)

A massive 13.5 cm sclerosing pneumocytoma in a 61-year-old female
by: Sampson K. Boham, et al.
Published: (2021-06-01)

Pulmonary sclerosing pneumocytoma containing spindle cells with sarcomatoid features: a case report with literature review
by: Jing Liang, et al.
Published: (2023-02-01)

Mathematical Models for FDG Kinetics in Cancer: A Review
by: Sara Sommariva, et al.
Published: (2021-08-01)

Clinical Characteristics of Malignant Pulmonary Sclerosing Pneumocytoma Based on a Study of 46 Cases Worldwide
by: Zhang W, et al.
Published: (2022-08-01)

Pulmonary Sclerosing Pneumocytoma: A Pre and Intraoperative Diagnostic Challenge. Report of Two Cases and Review of the Literature
by: Senia Maria Rosaria Trabucco, et al.
Published: (2021-05-01)

Metabolic tumor burden on postsurgical PET/CT predicts survival of patients with gastric cancer
by: Gaofeng Sun, et al.
Published: (2019-03-01)

Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography
by: Sawada S, et al.
Published: (2016-04-01)

Significant value of 18F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
by: Hao Peng, et al.
Published: (2017-12-01)

2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
by: U. Plöckinger, et al.
Published: (2018-03-01)

Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient
by: Christos Sachpekidis, et al.
Published: (2017-12-01)

Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging
by: Fu-Li Wang, et al.
Published: (2016-01-01)

Coincidence Planar Imaging for Dynamic [18F]FDG Uptake in Nude Mice with Tumors and Inflammation: Correlated With Histopathology and Micro-autoradiography
by: Ying-Ling Sun, et al.
Published: (2005-06-01)

The Correlation between CT Characteristics of Non-small Lung Cancer and the Performance of 18F-FDG PET and the Expression of Glut1 Protein
by: Xin WANG, et al.
Published: (2009-07-01)

Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder
by: F. Montes de Jesus, et al.
Published: (2021-03-01)

Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [<sup>18</sup>F]FDG PET/CT
by: Filipe Montes de Jesus, et al.
Published: (2021-01-01)

Reduction of Glucose Metabolism in Olfactory Bulb is an Earlier Alzheimer's Disease-related Biomarker in 5XFAD Mice
by: Nai-An Xiao, et al.
Published: (2015-01-01)

Unexpected -[18F] fluoro-2-deoxy-D-glucose accumulation in subarachnoid hemorrhage due to an aneurysm rupture
by: Hiroyuki Tokue, MD, et al.
Published: (2021-03-01)

The Contribution of [18]F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography to the diagnosis and staging of signet-ring cell carcinoma of the stomach
by: Selda Yilmaz Tatar, et al.
Published: (2021-01-01)

Correlation between tumor to liver SUV ratio and molecular subtypes of invasive breast carcinoma in PET CT
by: Nada Adel Awad El Kiki, et al.
Published: (2022-08-01)

Predictive value of Dmax and %ΔSUVmax of 18F-FDG PET/CT for the prognosis of patients with diffuse large B-cell lymphoma
by: Jun Dang, et al.
Published: (2023-10-01)